Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Cash Equivalents, at Carrying Value

2.9 / 5 stars · 23/40 Roast Me

RELMADA THERAPEUTICS, INC. Cash Equivalents, at Carrying Value

RELMADA THERAPEUTICS, INC. (RLMD) had Cash Equivalents, at Carrying Value of $2.09 million as of 2024-06-30, per its 10-Q filed 2024-08-07.

Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent

us-gaap:CashEquivalentsAtCarryingValue · last filed 2024-08-07

  • 2024-06-30: Cash Equivalents, at Carrying Value $2.09M.
  • 2024-03-31: Cash Equivalents, at Carrying Value $1.34M.
  • 2023-12-31: Cash Equivalents, at Carrying Value $4.09M.
  • 2023-06-30: Cash Equivalents, at Carrying Value $14.47M.
Period endCash Equivalents, at Carrying Value
2024-06-30$2.09M
10-Q · filed 2024-08-07
2024-03-31$1.34M
10-Q · filed 2024-05-08
2023-12-31$4.09M
10-K · filed 2024-03-19
2023-06-30$14.47M
10-Q · filed 2023-08-08
2023-03-31$28.89M
10-Q · filed 2023-05-11
2022-12-31$5.40M
10-K · filed 2023-03-23
2022-09-30$42.52M
10-Q · filed 2022-11-10
2022-06-30$37.26M
10-Q · filed 2022-08-11
2021-12-31$44.44M
10-K · filed 2022-03-25
2020-12-31$2.50M
10-K · filed 2022-03-25
2020-09-30$7.54M
10-Q · filed 2020-11-12
2019-12-31$36.28M
10-Q · filed 2020-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63